Cargando…

Identification of Key Genes of Human Advanced Diabetic Nephropathy Independent of Proteinuria by Transcriptome Analysis

BACKGROUND: Diabetic nephropathy (DN) is the leading cause of ESRD. Emerging evidence indicated that proteinuria may not be the determinant of renal survival in DN. The aim of the current study was to provide molecular signatures apart from proteinuria in DN by an integrative bioinformatics approach...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Fanghao, Zhou, Xujie, Jia, Yan, Yao, Weijian, Lv, Jicheng, Liu, Gang, Yang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336202/ https://www.ncbi.nlm.nih.gov/pubmed/32685522 http://dx.doi.org/10.1155/2020/7283581

Ejemplares similares

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
por: Dong, Yaping, et al.
Publicado: (2023)

The role of sirolimus in proteinuria in diabetic nephropathy rats
por: Wang, JinJun, et al.
Publicado: (2017)

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis
por: Zheng, Shirong, et al.
Publicado: (2016)

Urinary RBP as an Independent Predictor of Renal Outcome in Diabetic Nephropathy
por: Cai, Fanghao, et al.
Publicado: (2022)

The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study
por: Li, Hongfen, et al.
Publicado: (2022)

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission
por: Inagaki, Koji, et al.
Publicado: (2017)

Case Report: A Pathogenic Missense Variant of WT1 Cosegregates With Proteinuria in a Six-Generation Chinese Family With IgA Nephropathy
por: Li, Qianqian, et al.
Publicado: (2022)

Urinary Cystatin C and Tubular Proteinuria Predict Progression of Diabetic Nephropathy
por: Kim, Sang Soo, et al.
Publicado: (2013)

Tacrolimus decreases proteinuria in patients with refractory IgA nephropathy
por: Hu, Tingyang, et al.
Publicado: (2018)

Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2019)

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
por: Lv, Jicheng, et al.
Publicado: (2022)

The Role of Complement in Microangiopathic Lesions of IgA Nephropathy
por: Li, Jingyi, et al.
Publicado: (2022)

Multiple-microarray analysis for identification of key genes involved in diabetic nephropathy
por: Bi, Hui, et al.
Publicado: (2023)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
por: Hartono, Choli, et al.
Publicado: (2018)

Identification of key genes and pathways in diabetic nephropathy by bioinformatics analysis
por: Geng, Xiao‐dong, et al.
Publicado: (2019)

Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab
por: Hanna, Ramy M, et al.
Publicado: (2020)

Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria
por: Iwasaki, Chihiro, et al.
Publicado: (2016)

Effectiveness comparisons of acupuncture for diabetic nephropathy proteinuria: A systematic review and meta-analysis: study protocol
por: Miao, Yao-Dong, et al.
Publicado: (2019)

Benazepril hydrochloride improves diabetic nephropathy and decreases proteinuria by decreasing ANGPTL-4 expression
por: Xue, Lingyu, et al.
Publicado: (2017)

Addition of nonalbumin proteinuria to albuminuria improves prediction of type 2 diabetic nephropathy progression
por: Kim, Jong Ho, et al.
Publicado: (2017)

Anti-proteinuria effect of active vitamin D in patients with type 2 diabetic nephropathy
por: Aref, Asieh, et al.
Publicado: (2022)

Clinical Efficacy of Dapagliflozin in the Treatment of Patients with Diabetic Nephropathy and Its Effect on Proteinuria Level
por: Jin, Ze-Jun, et al.
Publicado: (2023)

Advanced Diabetic Nephropathy with Nephrotic Range Proteinuria: A Pilot Study of the Long-Term Efficacy of Subcutaneous ACTH Gel on Proteinuria, Progression of CKD, and Urinary Levels of VEGF and MCP-1
por: Tumlin, J. A., et al.
Publicado: (2013)

Podocyte-specific Rac1 deficiency ameliorates podocyte damage and proteinuria in STZ-induced diabetic nephropathy in mice
por: Lv, Zhimei, et al.
Publicado: (2018)

Proteinuria in Diabetes
por: Thomas, Stephen, et al.
Publicado: (2000)

Establishment and Validation of a Nomogram Model for Prediction of Diabetic Nephropathy in Type 2 Diabetic Patients with Proteinuria
por: Zhou, Dong-mei, et al.
Publicado: (2022)

Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial
por: Jo, Young-Il, et al.
Publicado: (2016)

P01-030 – Proteinuria in FMF – prediction of nephropathy type
por: Kukuy, OL, et al.
Publicado: (2013)

Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014)

Clinical Outcomes of Patients With Primary Membranous Nephropathy and Subnephrotic Proteinuria
por: He, Peng, et al.
Publicado: (2021)

Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy
por: Bagchi, Soumita, et al.
Publicado: (2022)

Weight loss for reduction of proteinuria in diabetic nephropathy: Comparison with angiotensin-converting enzyme inhibitor therapy
por: Patil, M. R., et al.
Publicado: (2013)

Curcumin as a major active component of turmeric attenuates proteinuria in patients with overt diabetic nephropathy
por: Vanaie, Azam, et al.
Publicado: (2019)

Demethylzeylasteral reduces the level of proteinuria in diabetic nephropathy: Screening of network pharmacology and verification by animal experiment
por: Xu, Lengnan, et al.
Publicado: (2022)

The predictive value and response to immunosuppressive therapy of IgA nephropathy patients with crescents in a large retrospective Chinese cohort
por: Guo, Yingman, et al.
Publicado: (2023)

Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study
por: Yang, Ya-zi, et al.
Publicado: (2019)

Glomerulosclerosis is a prognostic risk factor in patients with membranous nephropathy and non-nephrotic proteinuria
por: Sun, Jing, et al.
Publicado: (2023)

Terahertz spectra of proteinuria and non-proteinuria
por: Xue, Zhenrui, et al.
Publicado: (2023)

Canagliflozin Markedly Decreased Proteinuria in a Patient With IgA Nephropathy
por: Aameish, Muhammad, et al.
Publicado: (2021)

Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n98vii1rlhc447gj0l1gj41el7